Skip to content

LAVA Therapeutics NV

🇺🇸XNAS.LVTXUnited StatesHealthcare

$1.74USDunchanged 0.00 (0%)OpenEnd of day5:03 PM

Price$1.740.00 (0%)

Profile

  • Healthcare
  • Biotechnology
  • United States

Identity

Exchange
Nasdaq . XNAS
Type
Stock
ISIN
NL0015000AG6
CUSIP

Company

Employees
10
Headquarters
Utrecht, United States
CEO
Mr. Stephen Allen Hurly M.B.A., M.Sc.

Market

Shares outstanding
26.3M
Market cap
$45.77M

Highlights

No high and low reported for today's session.

52-week range$1.40 - $1.82
from 52 sessions, less than a full year
Market cap
$45.77M
EPS LTM
-$0.88calculatedCalculated by Finzer, not reported by the data provider.
P/E LTM
-1.97calculatedCalculated by Finzer, not reported by the data provider.
Div yield
Not reported

Fundamentals (LTM)

Revenue
$4.99M-34.11%down year on year
Net income
-$23.28M+15.98%up year on year
Gross margin
-394.29%-543.55%down year on year
Free cash flow
-$31.67M-10.23%down year on year

View all financials

Other listings

This company is not listed on any other exchange we cover.

These are the venues Finzer covers, not every venue that exists.

Business summary

No company summary reported yet.